Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase NA 1

Status

Recruiting 41Completed 26Active not recruiting 20Terminated 10Unknown 7Not yet recruiting 7Withdrawn 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Lymphoid 7Other hematologic neoplasm 2

Conditions

Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2Waldenstrom Macroglobulinemia 1Lymphoma, Large B-Cell, Diffuse 1Indolent Non-Hodgkin Lymphoma 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Unknown × obinutuzumab × Clear all
NCT05387616 2024-03-12

Alternative-C

Ludwig-Maximilians - University of Munich

Phase 2 Unknown
98 enrolled
Lymphoid

Lymphoma, Follicular

NCT05823701 2023-04-21

Chidamide, Azacitidine Combined With GM Regimen for Relapsed and Refractory DLBCL Patients

The First Affiliated Hospital of Soochow University

Phase 2 Unknown
23 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05322733 2022-04-19

Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Unknown
25 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04934930 2021-06-22

FLMRD

Meir Medical Center

Phase 2 Unknown
40 enrolled
Lymphoid

Lymphoma, Follicular

NCT02689869 2021-05-07

Alternative

Ludwig-Maximilians - University of Munich

Phase 2 Unknown
98 enrolled
Lymphoid

Indolent Non-Hodgkin Lymphoma

NCT04059081 2019-08-16

A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment

Chonnam National University Hospital

Phase 2 Unknown
31 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT03679455 2018-11-13

OBI-1

Polish Myeloma Consortium

Phase 2 Unknown
30 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡